Why Does Folliculitis Decalvans Relapse After Antibiotics?
At a Glance
Folliculitis decalvans often returns after antibiotics because treatment may reduce bacteria and active inflammation without removing the immune tendency driving the disease. A dermatologist can assess the flare and tailor testing, maintenance treatment, or non-antibiotic options.
It is incredibly frustrating when Quinquaud folliculitis decalvans (FD) flares up again after a successful course of antibiotics. Relapse is very common and usually does not mean you did anything wrong. FD is a chronic, scarring inflammatory condition of the hair follicles, not just a simple, temporary infection. While antibiotics can reduce bacteria and calm active inflammation, they often do not eliminate the underlying immune tendency that drives the condition [1][2].
Why Relapse Happens
When a flare occurs after stopping antibiotics, it is usually because the underlying drivers of the disease are still active. Several factors can contribute:
- Ongoing Inflammation: Research shows that people with FD have an overactive immune response in their hair follicles, producing excess inflammatory signals [3][4]. This immune system overreaction can cause chronic inflammation to return even if bacteria were successfully reduced during treatment.
- The Complex Role of Bacteria: The bacteria Staphylococcus aureus (Staph) is frequently found on the scalp of people with FD, sometimes even in areas that appear completely healthy [5]. However, the exact role of these bacteria is still debated—it is not fully settled whether they cause the disease or simply thrive in the inflamed environment. While a relapse might involve persistent bacteria, different strains, or antibiotic resistance [6][7], a flare often simply means the underlying inflammation has returned.
Because FD is a chronic condition, it is common for symptoms to return when treatment stops. For example, in one small retrospective study of 28 patients, 80% experienced a relapse after completing a course of the combined antibiotics clindamycin and rifampicin [2]. Relapse rates vary, but this highlights that a standard course of antibiotics rarely provides a permanent cure.
What Can Be Done?
If your symptoms have returned, the most important step is to see your dermatologist. Do not simply restart leftover antibiotics or change your dose on your own. Taking antibiotics without supervision can lead to serious risks, including antimicrobial resistance, severe diarrhea, and liver injury [2]. Your care team can help you develop a safe, long-term strategy:
- Targeted Testing: If your FD is not responding to standard treatments or if the flare is unusual, your doctor may take a swab of an active pustule (a small pus-filled bump) for a bacterial culture. While a culture cannot guarantee a specific treatment will work, it helps guide medication choices [7][8]. Additionally, if overlapping conditions (like lichen planopilaris) are suspected, a small scalp biopsy may be used to help confirm the exact diagnosis [9][10].
- Specialist-Directed Maintenance Treatment: Short courses of antibiotics are often not enough for long-term control. The European Academy of Dermatology and Venereology (EADV) suggests that carefully monitored treatment extending beyond the clearing of visible symptoms may be considered by your specialist to help prevent relapse [11]. Because prolonged antibiotics carry significant health risks, this requires a customized plan and regular medical monitoring [12].
- Exploring Alternative Medications: Depending on your health and the severity of the flare, your doctor might discuss non-antibiotic treatments. Options may include oral isotretinoin, a medication that can offer more durable remission for some patients but requires strict medical monitoring and pregnancy prevention [13][2]. For highly active inflammation, a short course of oral corticosteroids (which also carry short- and long-term risks) or other systemic medicines might be used to quickly calm the scalp [11].
Next Steps and Expectations
The main goal of any treatment plan for FD is to control the inflammation, relieve symptoms like pain and itching, and prevent further permanent hair loss—not to regrow hair in follicles that have already scarred [11].
While waiting for your appointment, you can photograph any new pustules to show your doctor. Seek prompt medical attention if you develop rapidly spreading redness, severe pain, feeling very unwell, or if you experience concerning medication effects such as severe or bloody diarrhea.
Common questions in this guide
Why can folliculitis decalvans return after antibiotics?
Does a relapse mean I still have an infection or need a stronger antibiotic?
Should I restart leftover antibiotics when my scalp flares?
What tests can help explain a folliculitis decalvans relapse?
What treatments may help prevent future folliculitis decalvans flares?
Can treatment regrow hair lost from folliculitis decalvans?
Related questions
Show more
Get notified when new evidence is published on Quinquaud folliculitis decalvans.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Navigating Treatments in Folliculitis Decalvans: A Comprehensive Systematic Review.
Al-Naesan I, Trafoier T, Krepper D, et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2026; doi:10.1111/ddg.70607.
PMID: 42750403 - 2
Oral isotretinoin as the most effective treatment in folliculitis decalvans: a retrospective comparison of different treatment regimens in 28 patients.
Tietze JK, Heppt MV, von Preußen A, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(9)):1816-21 doi:10.1111/jdv.13052.
PMID: 25712452 - 3
Folliculitis Decalvans Has a Heterogeneous Microbiological Signature and Impaired Immunological Response.
Moreno-Arrones OM, Garcia-Hoz C, Del Campo R, et al.
Dermatology (Basel, Switzerland) 2023; (239(3)):454-461 doi:10.1159/000529301.
PMID: 36716709 - 4
Evidence of interleukin-17-secreting mast cells in scalp lesions of folliculitis decalvans points to new therapeutic targets in recalcitrant lesions.
Franciozi AB, Sotto MN, Rivitti-Machado MCM, et al.
Clinical and experimental dermatology 2025; (50(3)):629-631 doi:10.1093/ced/llae421.
PMID: 39388582 - 5
Folliculitis decalvans is characterized by a persistent, abnormal subepidermal microbiota.
Matard B, Donay JL, Resche-Rigon M, et al.
Experimental dermatology 2020; (29(3)):295-298 doi:10.1111/exd.13916.
PMID: 30907453 - 6
Scalp microbiome: a guide to better understanding scalp diseases and treatments.
Shah RR, Larrondo J, Dawson T, Mcmichael A
Archives of dermatological research 2024; (316(8)):495 doi:10.1007/s00403-024-03235-2.
PMID: 39073596 - 7
Gram-negative infections in patients with folliculitis decalvans: a subset of patients requiring alternative treatment.
Samrao A, Mirmirani P
Dermatology online journal 2020; (26(2)).
PMID: 32239885 - 8
Diagnostic delay, comorbid hidradenitis suppurativa and the prognostic value of bacterial culture in folliculitis decalvans: A cohort study.
Lyakhovitsky A, Segal O, Galili E, et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2023; (21(12)):1469-1477 doi:10.1111/ddg.15202.
PMID: 37875786 - 9
Linear Circumscribed Scleroderma-Like Folliculitis Decalvans: Yet Another Face of a Protean Condition.
Rezende HD, Dias MFRG, Kempf W, Treüb RM
International journal of trichology 2018; (10(4)):175-179 doi:10.4103/ijt.ijt_9_18.
PMID: 30386078 - 10
Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum-A Series of 7 New Cases With Focus on Histopathology.
Egger A, Stojadinovic O, Miteva M
The American Journal of dermatopathology 2020; (42(3)):173-177 doi:10.1097/DAD.0000000000001595.
PMID: 31855586 - 11
Management of folliculitis decalvans: The EADV task force on hair diseases position statement.
Waśkiel-Burnat A, Starace M, Iorizzo M, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2025; (39(8)):1385-1394 doi:10.1111/jdv.20687.
PMID: 40230058 - 12
Retrospective Review of Folliculitis Decalvans in 23 Patients with Course and Treatment Analysis of Long-standing Cases.
Bunagan MJ, Banka N, Shapiro J
Journal of cutaneous medicine and surgery 2014; (18(5)):1-5.
PMID: 25277850 - 13
Isotretinoin treatment for folliculitis decalvans: a retrospective case-series study.
Aksoy B, Hapa A, Mutlu E
International journal of dermatology 2018; (57(2)):250-253 doi:10.1111/ijd.13874.
PMID: 29313960
This page is for informational purposes only and does not constitute medical advice about a folliculitis decalvans relapse. Consult a dermatologist before restarting antibiotics or changing treatment.